Bowen T R, Miller F, Mackenzie W
Department of Orthopaedics, The Alfred I. duPont Hospital for Children, Wilmington, Delaware 19899, USA.
J Pediatr Orthop. 1999 Jan-Feb;19(1):133-6.
Children with muscular dystrophy (MD) offer a unique opportunity to measure the effect of weakness on gait efficiency as they experience weakness not usually accompanied by other disabilities affecting gait. Oxygen consumption measurements were collected from eight patients with MD and eight patients with cerebral palsy (CP). A statistically significant difference in oxygen cost and oxygen consumption while walking between patients with CP and patients with MD was found despite their common inability to walk similar distances. Oxygen cost and oxygen consumption were elevated within the CP population, whereas all measurements for the MD population were within normal ranges. The measurements show that a patient can have normal oxygen cost and oxygen consumption while walking and yet be functionally limited because of weakness. Caution should be taken when using oxygen cost and oxygen consumption as sole outcome measures for patients with CP, because these measures may be insensitive to changes in strength.
患有肌肉萎缩症(MD)的儿童为测量肌无力对步态效率的影响提供了一个独特的机会,因为他们所经历的肌无力通常不会伴有影响步态的其他残疾。收集了8名MD患者和8名脑瘫(CP)患者的耗氧量测量数据。尽管CP患者和MD患者都普遍无法行走相似的距离,但发现他们行走时的氧耗量和耗氧量存在统计学上的显著差异。CP患者群体的氧耗量和耗氧量升高,而MD患者群体的所有测量值都在正常范围内。这些测量结果表明,患者行走时可以有正常的氧耗量和耗氧量,但由于肌无力,其功能仍会受到限制。对于CP患者,将氧耗量和耗氧量作为唯一的结果指标时应谨慎,因为这些指标可能对力量变化不敏感。